HEALTH: Harnessing Epidemiology to Advance Lupus Treatment and Health
健康:利用流行病学促进狼疮治疗和健康
基本信息
- 批准号:10668437
- 负责人:
- 金额:$ 90万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-30 至 2027-09-29
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
ABSTRACT
Lupus remains a leading cause of death in young women, with racial/ethnic minority patients having worse
long-term outcomes, including progression to end stage renal disease and overall mortality, and poorer
intermediate outcomes of disease activity and damage accrual. Further, manifestations of lupus affect physical
function, fatigue, pain, and other patient-reported outcomes, potentially leading to challenges with maintaining
everyday activities and function, which are linked to better quality of life, productivity, and survival. Finally, a
major challenge in SLE management is delayed identification of early kidney disease, which ultimately leads to
a greater burden on both patients and the health system. In response to the CDC NOFO RFA-DP-22-002,
Component A, “Epidemiology of Lupus: Longitudinal Studies in Population-Based Cohorts,” this proposal
leverages our well-established, longitudinal, ethnically/racially and socioeconomically diverse, and
phenotypically well-characterized cohort of patients with lupus. This proposal’s overarching goals include
clarifying the long-term natural history of SLE by evaluating disease severity, morbidity, and multi-morbidity;
assessing disparities in illness experience associated with race/ethnicity, age, and socioeconomic status;
collecting novel biospecimens to potentially differentiate roots of pain/fatigue syndromes; and evaluating a
novel strategy to identify early kidney disease in high-risk patients. The NYU Lupus Cohort is a “living”
biorepository with >900 patients enrolled, three-quarters followed at least twice annually, with diverse
backgrounds (50% minority race; 30% Hispanic) and socioeconomic status (31% public hospital patients) who
provide samples over time. Data include demographics, established classification criteria over time,
medications, routine metabolic and hematologic parameters, laboratory-based urine analysis, autoantibody
profiles, disease activity fluctuations and organ damage accrual using validated instruments, patient-reported
outcomes, and measures for socioeconomic status and position, and material, behavioral, psychosocial, health
system, and health outcomes. We propose to extend our longitudinal Cohort with linkage to electronic health
records and state-wide, all-payer claims data for comorbidity data, new cytokine profiles and transcriptomic
modules, and implementating a novel strategy to identify early kidney disease. Our multidisciplinary team will
address three Specific Aims: 1) Quantify multimorbidity and major healthcare use in patients with lupus to
improve understanding of lupus and non-lupus comorbidities, including disparities by sociodemographic
factors; 2) Measure the burden of lupus on quality of life, with analyses to assess disparities by
sociodemographic factors, behavioral and psychosocial factors, and genetic information; and 3) Develop and
evaluate innovative, technology-driven home-based proteinuria testing for patients at elevated risk of nephritis.
Overall, this study is anticipated to provide a significantly improved understanding of lupus epidemiology,
including lupus-related morbidity and quality of life, and targets for interventions to manage patients with lupus.
摘要
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Clinical and Serologic Phenotyping and Damage Indices in Patients With Systemic Lupus Erythematosus With and Without Fibromyalgia.
伴有或不伴有纤维肌痛的系统性红斑狼疮患者的临床和血清学表型及损伤指数。
- DOI:10.1002/acr2.11641
- 发表时间:2024
- 期刊:
- 影响因子:3.4
- 作者:Corbitt,Kelly;Carlucci,PhilipM;Cohen,Brooke;Masson,Mala;Saxena,Amit;Belmont,HMichael;Tseng,Chung-E;Barbour,KamilE;Gold,Heather;Buyon,Jill;Izmirly,Peter
- 通讯作者:Izmirly,Peter
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jill P Buyon其他文献
Substantiation of trophoblast transport of maternal anti-SSA/Ro autoantibodies in fetuses with rapidly progressive cardiac injury: implications for neonatal Fc receptor blockade
母体抗 SSA/Ro 自身抗体经滋养层转运至有快速进展性心脏损伤胎儿中的证据:对新生儿 Fc 受体阻断的意义
- DOI:
10.1016/s2665-9913(24)00331-x - 发表时间:
2025-01-01 - 期刊:
- 影响因子:16.400
- 作者:
Jill P Buyon;Philip M Carlucci;Bettina F Cuneo;Mala Masson;Peter Izmirly;Nalani Sachan;Justin S Brandt;Shilpi Mehta-Lee;Marc Halushka;Kristen Thomas;Melanie Fox;Colin KL Phoon;Achiau Ludomirsky;Ranjini Srinivasan;Garrett Lam;Benjamin J Wainwright;Nicola Fraser;Robert Clancy - 通讯作者:
Robert Clancy
Cardiac manifestations of neonatal lupus erythematosus: guidelines to management, integrating clues from the bench and bedside
新生儿红斑狼疮的心脏表现:管理指南,整合实验台和病床旁的线索
- DOI:
10.1038/ncprheum1018 - 发表时间:
2009-03-01 - 期刊:
- 影响因子:32.700
- 作者:
Jill P Buyon;Robert M Clancy;Deborah M Friedman - 通讯作者:
Deborah M Friedman
A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes
索马鲁肽治疗 2 型糖尿病患者的心脏病研究
- DOI:
- 发表时间:
2019 - 期刊:
- 影响因子:0
- 作者:
Devyn Zaminski;Amit Saxena;P. Izmirly;Jill P Buyon;H. M. Belmont - 通讯作者:
H. M. Belmont
Jill P Buyon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jill P Buyon', 18)}}的其他基金
Stopping Hydroxychloroquine In Elderly Lupus Disease (SHIELD)
停止使用羟氯喹治疗老年狼疮病 (SHIELD)
- 批准号:
10594743 - 财政年份:2023
- 资助金额:
$ 90万 - 项目类别:
Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT) - Pain Supplement
狼疮组学皮肤肾脏调查小组 (LOCKIT) - 疼痛补充剂
- 批准号:
10861419 - 财政年份:2022
- 资助金额:
$ 90万 - 项目类别:
Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT)
狼疮组学皮肤肾研究小组 (LOCKIT)
- 批准号:
10452169 - 财政年份:2022
- 资助金额:
$ 90万 - 项目类别:
Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT)
狼疮组学皮肤肾研究小组 (LOCKIT)
- 批准号:
10596281 - 财政年份:2022
- 资助金额:
$ 90万 - 项目类别:
HEALTH: Harnessing Epidemiology to Advance Lupus Treatment and Health
健康:利用流行病学促进狼疮治疗和健康
- 批准号:
10552857 - 财政年份:2022
- 资助金额:
$ 90万 - 项目类别:
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
监测和治疗以预防胎儿房室传导阻滞可能很快发生(STOP BLOQ)
- 批准号:
10250529 - 财政年份:2020
- 资助金额:
$ 90万 - 项目类别:
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
监测和治疗以预防胎儿房室传导阻滞可能很快发生(STOP BLOQ)
- 批准号:
10440476 - 财政年份:2020
- 资助金额:
$ 90万 - 项目类别:
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
监测和治疗以预防胎儿房室传导阻滞可能很快发生(STOP BLOQ)
- 批准号:
10644022 - 财政年份:2020
- 资助金额:
$ 90万 - 项目类别:
Mechanisms of DNA-Specific Autoimmunity in Systemic Lupus Erythematosus
系统性红斑狼疮 DNA 特异性自身免疫机制
- 批准号:
10374852 - 财政年份:2018
- 资助金额:
$ 90万 - 项目类别:
Translational Center of Molecular Profiling in Preclinical and Established Lupus (COMPEL)
临床前和已确诊狼疮分子分析转化中心 (COMPEL)
- 批准号:
9766075 - 财政年份:2017
- 资助金额:
$ 90万 - 项目类别:
相似海外基金
Harnessing creative heritage for migrant wellbeing in museums and libraries
利用博物馆和图书馆的创意遗产促进移民福祉
- 批准号:
DE240100336 - 财政年份:2024
- 资助金额:
$ 90万 - 项目类别:
Discovery Early Career Researcher Award
Harnessing the power of ordinary people to prevent cyber abuse
利用普通人的力量来防止网络滥用
- 批准号:
DE240100080 - 财政年份:2024
- 资助金额:
$ 90万 - 项目类别:
Discovery Early Career Researcher Award
Harnessing the Power of Diels-Alderases in Sustainable Chemoenzymatic Synthesis
利用 Diels-Alderases 进行可持续化学酶合成
- 批准号:
BB/Y000846/1 - 财政年份:2024
- 资助金额:
$ 90万 - 项目类别:
Research Grant
CAREER: Harnessing Dynamic Dipoles for Solid-State Ion Transport
职业:利用动态偶极子进行固态离子传输
- 批准号:
2339634 - 财政年份:2024
- 资助金额:
$ 90万 - 项目类别:
Continuing Grant
CAREER: Foundational Principles for Harnessing Provenance Analytics for Advanced Enterprise Security
职业:利用来源分析实现高级企业安全的基本原则
- 批准号:
2339483 - 财政年份:2024
- 资助金额:
$ 90万 - 项目类别:
Continuing Grant
CLIMA/Collaborative Research: Enhancing Soil-Based Infrastructure Resilience to Climate Change: Harnessing the Potential of Fractured Soil by Adding Biopolymers
CLIMA/合作研究:增强土壤基础设施对气候变化的抵御能力:通过添加生物聚合物来利用破碎土壤的潜力
- 批准号:
2332082 - 财政年份:2024
- 资助金额:
$ 90万 - 项目类别:
Continuing Grant
Harnessing mega-constellations to probe space weather globally
利用巨型星座探测全球空间天气
- 批准号:
MR/X034704/1 - 财政年份:2024
- 资助金额:
$ 90万 - 项目类别:
Fellowship
Harnessing Magnonic Nonreciprocity Through Dissipation Engineering
通过耗散工程利用磁非互易性
- 批准号:
2337713 - 财政年份:2024
- 资助金额:
$ 90万 - 项目类别:
Standard Grant
Harnessing a novel nematode protein for safe and specific RNA delivery to cells
利用新型线虫蛋白将 RNA 安全且特异性地递送至细胞
- 批准号:
EP/Y037251/1 - 财政年份:2024
- 资助金额:
$ 90万 - 项目类别:
Research Grant
Harnessing the potential of Archaea - Training Europe's next visionaries for an innovative and sustainable future
利用古生菌的潜力 - 培训欧洲的下一代有远见的人以实现创新和可持续的未来
- 批准号:
EP/Y031407/1 - 财政年份:2024
- 资助金额:
$ 90万 - 项目类别:
Research Grant